Peptides, your cycle and fertility

Should I time peptides to my menstrual cycle, and what changes across phases?

The menstrual cycle changes the hormonal background peptides act on, so the same protocol can feel different across phases. But evidence for deliberately timing peptides to cycle phase is thin — track and observe rather than chase a schedule. The one hard rule is reproductive intent: if a cycle could end in conception, pregnancy-safety rules take over.

Medically reviewedRead →

How do GLP-1s affect women specifically — PCOS, fertility, and contraception?

GLP-1s are unusually well-studied in women. They improve weight, insulin resistance, and often menstrual regularity in PCOS; they can restore ovulation (so unplanned pregnancy is a real risk); and they carry a hard pre-conception stop because of their long washout. They are not a fertility drug — the fertility effect is a downstream consequence of weight and metabolic improvement.

Medically reviewedRead →

What do women with PCOS report on Mounjaro or Ozempic, and how does it compare with the trials?

The weight loss women with PCOS describe on Mounjaro and Ozempic matches the research: a large UK cohort found about 19% loss at 10 months, similar to women without PCOS. Fertility benefits rest on small trials without live-birth outcomes, regain data come from non-PCOS trials, and the 2023 guideline limits fertility use to research.

Medically reviewedRead →

Do GLP-1 medications affect birth control, and how long before pregnancy should they be stopped?

Tirzepatide and semaglutide carry opposite warnings, and almost every article on this subject blurs them together. Tirzepatide can reduce absorption of oral contraceptives, and its label requires switching to a non-oral method or adding a barrier method for four weeks after starting and four weeks after every dose increase. Semaglutide carries no contraceptive warning at all — the interaction was studied and found not clinically relevant. Reverse that for pregnancy planning: semaglutide labels advise stopping at least two months before a planned pregnancy, while tirzepatide labels specify no washout period.

Medically reviewedRead →

Which peptides are safe in pregnancy and breastfeeding, and what should I stop?

No peptide has adequate human safety data in pregnancy or breastfeeding, so the responsible default is avoidance. GLP-1s need a planned pre-conception stop because of their long washout. For research peptides with no pregnancy data at all, 'we don't know' should be read as 'don't' — the risk is asymmetric and the intervention is deferrable.

Medically reviewedRead →

Is methyl folate better than folic acid?

L-methylfolate is the active form of folate and raises blood folate at least as well as folic acid, but only folic acid is proven in randomized trials to prevent neural tube defects. US guidance recommends 400 to 800 micrograms of folic acid for anyone who could become pregnant, including people with MTHFR variants.

Medically reviewedRead →

Do peptides help endometriosis?

Yes, but only prescription GnRH agonists such as leuprolide and goserelin. Their pain evidence is rated low certainty and they cause bone loss, so use is time-limited. BPC-157, KPV and thymosin alpha-1 have no endometriosis studies, and GLP-1 drugs and kisspeptin remain research ideas.

Medically reviewedRead →